We are analyzing https://link.springer.com/article/10.1007/bf01806079.

Title:
Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines | Breast Cancer Research and Treatment
Description:
The ability to maintain and study human tissues in anin vivo environment has proved to be a valuable tool in breast cancer research for several decades. The most widely studied tissues have been xenografts of established human breast cancer cell lines into athymic nude mice. Human breast tumor xenografts provide the opportunity to study various important interactions between the tumor and host tissues, including endocrinologic, immunologic, and tumor-stroma interactions. The nude mouse is not the only immune-deficient recipient system in which to study xenografts. Additional single and combined mutant strains have been used successfully, including mice homozygous for the severe combined immune deficiency mutation (scid), both the beige (bg) and nude (nu) mutations in combination (bg/nu), and mice bearing the combinedbg/nu/xid mutations. The differing immunobiologies are discussed, with particular reference to the immunobiology of breast cancer, as are the characteristics of several of the more frequently utilized breast cancer xenografts and cell lines. The ability of several endocrine treatments to modulate effectors of cell mediated immunity,e.g., estrogens and antiestrogens, and the effect of site of inoculation on tumor take and metastasis, also are described.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

google, scholar, cancer, pubmed, breast, human, cell, mice, cells, nude, res, growth, natural, killer, tumor, clarke, lippman, mouse, metastasis, immunol, mcf, lines, resistance, xenografts, athymic, combined, scid, tumors, brünner, dickson, exp, line, models, severe, characterization, activity, article, natl, receptor, med, factor, immunodeficiency, bosma, content, carcinoma, nature, metastatic, int, expression, antiestrogen,

Topics {✒️}

activated c-harasej/psv2neo genes x-linked b-lymphocyte defect x-linked immune-deficient mice month download article/chapter il-2-inducible killer cells lymphokine-activated killer cells tamoxifen-resistant breast cancer breast cancer patient natural cell-mediated immunity anti-pd-1-based therapy macrophage colony-stimulating factor rat mammary cells immune-deficient recipient system human cell line macrophage-mediated tumor cytolysis natural killer-deficient mice murine cell lines tumorigenic cell lines human tumour xenografts long-term antiestrogen administration long-term antiestrogen therapy human tumor xenografts breast cancer research autologous breast cancer congenitally immune-deficient mice rat mammary carcinomas oestrogen receptor expression human breast carcinoma human breast cancer combinedbg/nu/xid mutations increased basement membrane-invasiveness β-estradiol treatment human breast disease tamoxifen resistant variant tamoxifen-resistant variant natural killer cells human breast tumors xenograft ascites model b-lymphocyte heterogeneity murine tumor cells colon cancer cells human breast carcinomas cell mediated immunity molecular biology solitary tumors derived natural killer activity hormone-responsive variants breast cancer patients privacy choices/manage cookies ii-nu/nu mice

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines
         description:The ability to maintain and study human tissues in anin vivo environment has proved to be a valuable tool in breast cancer research for several decades. The most widely studied tissues have been xenografts of established human breast cancer cell lines into athymic nude mice. Human breast tumor xenografts provide the opportunity to study various important interactions between the tumor and host tissues, including endocrinologic, immunologic, and tumor-stroma interactions. The nude mouse is not the only immune-deficient recipient system in which to study xenografts. Additional single and combined mutant strains have been used successfully, including mice homozygous for the severe combined immune deficiency mutation (scid), both the beige (bg) and nude (nu) mutations in combination (bg/nu), and mice bearing the combinedbg/nu/xid mutations. The differing immunobiologies are discussed, with particular reference to the immunobiology of breast cancer, as are the characteristics of several of the more frequently utilized breast cancer xenografts and cell lines. The ability of several endocrine treatments to modulate effectors of cell mediated immunity,e.g., estrogens and antiestrogens, and the effect of site of inoculation on tumor take and metastasis, also are described.
         datePublished:
         dateModified:
         pageStart:69
         pageEnd:86
         sameAs:https://doi.org/10.1007/BF01806079
         keywords:
            xenografts
            breast cancer
            cell lines
            resistance
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:39
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Robert Clarke
               affiliation:
                     name:Georgetown University Medical School
                     address:
                        name:Vincent T. Lombardi Cancer Center and Department of Physiology & Biophysics, W405A The Research Building, Georgetown University Medical School, Washington DC, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines
      description:The ability to maintain and study human tissues in anin vivo environment has proved to be a valuable tool in breast cancer research for several decades. The most widely studied tissues have been xenografts of established human breast cancer cell lines into athymic nude mice. Human breast tumor xenografts provide the opportunity to study various important interactions between the tumor and host tissues, including endocrinologic, immunologic, and tumor-stroma interactions. The nude mouse is not the only immune-deficient recipient system in which to study xenografts. Additional single and combined mutant strains have been used successfully, including mice homozygous for the severe combined immune deficiency mutation (scid), both the beige (bg) and nude (nu) mutations in combination (bg/nu), and mice bearing the combinedbg/nu/xid mutations. The differing immunobiologies are discussed, with particular reference to the immunobiology of breast cancer, as are the characteristics of several of the more frequently utilized breast cancer xenografts and cell lines. The ability of several endocrine treatments to modulate effectors of cell mediated immunity,e.g., estrogens and antiestrogens, and the effect of site of inoculation on tumor take and metastasis, also are described.
      datePublished:
      dateModified:
      pageStart:69
      pageEnd:86
      sameAs:https://doi.org/10.1007/BF01806079
      keywords:
         xenografts
         breast cancer
         cell lines
         resistance
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:39
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Robert Clarke
            affiliation:
                  name:Georgetown University Medical School
                  address:
                     name:Vincent T. Lombardi Cancer Center and Department of Physiology & Biophysics, W405A The Research Building, Georgetown University Medical School, Washington DC, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:39
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Georgetown University Medical School
      address:
         name:Vincent T. Lombardi Cancer Center and Department of Physiology & Biophysics, W405A The Research Building, Georgetown University Medical School, Washington DC, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Robert Clarke
      affiliation:
            name:Georgetown University Medical School
            address:
               name:Vincent T. Lombardi Cancer Center and Department of Physiology & Biophysics, W405A The Research Building, Georgetown University Medical School, Washington DC, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Vincent T. Lombardi Cancer Center and Department of Physiology & Biophysics, W405A The Research Building, Georgetown University Medical School, Washington DC, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(291)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.3s.

LINK . SPRINGER . COM {}